M

new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987, 6 (11), 3341-3351.

15. Qiu, F.H.; Ray, P.; Brown, K.; Barker, P.E.; Jhanwar, S.; Ruddle, F.H.; Besmer, P. Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinase family—Oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 1988, 7 (4), 1003-1011.

16. Linnekin, D. Early signaling pathways activated by c-kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 1999, 31 (10), 1053-1074.

17. Serve, H.; Yee, N.S.; Stella, G.; Sepp-Lorenzino, L.; Tan, J.C.; Besmer, P. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 1995, 14 (3), 473-483.

18. Vosseller, K.; Stella, G.; Yee, N.S.; Besmer, P. c-Kit receptor signaling through its phosphatidylinositide-3'-kinase-binding site and protein kinase C: Role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol. Biol. Cell 1997, 8 (5), 909-922.

19. Thommes, K.; Lennartsson, J.; Carlberg, M.; Ronnstrand, L. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor. Biochem. J. 1999, 341 (Part 1), 211-216.

20. Ryan, J.J.; Huang, H.; McReynolds, L.J.; Shelburne, C.; Hu-Li, J.; Huff, T.F.; Paul, W.E. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells. Exp. Hematol. 1997, 25 (4), 357-362.

21. Kitayama, H.; Kanakura, Y.; Furitsu, T.; Tsujimura, T.; Oritani, K.; Ikeda, H.; Sugahara, H.; Mitsui, H.; Kanayama, Y.; Kitamura, Y. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoi-etic cell lines. Blood 1995, 85 (3), 790-798.

22. Tsujimura, T.; Hashimoto, K.; Kitayama, H.; Ikeda, H.; Sugahara, H.; Matsumura, I.; Kaisho, T.; Terada, N.; Kitamura, Y.; Kanakura, Y. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site. Blood 1999, 93 (4), 1319-1329.

23. Chian, R.; Young, S.; Danilkovitch-Miagkova, A.; Ronnstrand, L.; Leonard, E.; Ferrao, P.; Ashman, L.; Linnekin, D. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-kit mutant. Blood 2001, 98 (5), 1365-1373.

24. Sotlar, K.; Marafioti, T.; Griesser, H.; Theil, J.; Aepinus, C.; Jaussi, R.; Stein, H.; Valent, P.; Horny, H.P. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. Mol. Pathol. 2000, 53 (4), 188-193.

25. Sotlar, K.; Escribano, L.; Landt, O.; Mohrle, S.; Herrero, S.; Torrelo, A.; Lass, U.; Horny, H.P.; Bultmann, B. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am. J. Pathol. 2003, 162 (3), 737-746.

26. Yavuz, A.S.; Lipsky, P.E.; Yavuz, S.; Metcalfe, D.D.; Akin, C. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood 2002, 100 (2), 661-665.

27. Fritsche-Polanz, R.; Jordan, J.H.; Feix, A.; Sperr, W.R.; Sunder-Plassmann, G.; Valent, P.; Fodinger, M. Mutation analysis of c-kit in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br. J. Haematol. 2001, 113 (2), 357-364.

28. Jordan, J.H.; Fritsche-Polanz, R.; Sperr, W.R.; Mitterbauer, G.; Fodinger, M.; Schernthaner, G.H.; Christian, B.H.; Gebhart, W.; Chott, A.; Lechner, K.; Valent, P. A case of ''smouldering'' mastocytosis with high mast cell burden, monoclonal myeloid cells, and c-kit mutation Asp-816-Val. Leuk. Res. 2001, 25 (7), 627-634.

29. Hauswirth, A.W.; Sperr, W.R.; Ghannadan, M.; Schernthaner, G.H.; Jordan, J.H.; Fritsche-Polanz, R.; Simonitsch-Klupp, I.; Fodinger, M.; Lechner, K.; Valent, P. A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy. Leuk. Res. 2002, 26 (6), 601-606.

30. Valent, P.; Akin, C.; Sperr, W.R.; Horny, H.P.; Metcalfe, D.D. Smouldering mastocytosis: A novel subtype of systemic mastocytosis with slow progression. Int. Arch. Allergy Immunol. 2002, 127 (2), 137-139.

31. Buchdunger, E.; Cioffi, C.L.; Law, N.; Stover, D.; Ohno-Jones, S.; Druker, B.J.; Lydon, N.B. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 2000, 295 (1), 139145.

32. Zermati, Y.; De Sepulveda, P.; Feger, F.; Letard, S.; Kersual, J.; Casteran, N.; Gorochov, G.; Dy, M.; Ribadeau, D.A.; Dorgham, K.; Parizot, C.; Bieche, Y.; Vidaud, M.; Lortholary, O.; Arock, M.; Hermine, O.; Dubreuil, P. Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene 2003, 22 (5), 660-664.

33. Akin, C.; Brockow, K.; D'Ambrosio, C.; Kirshenbaum, A.S.; Yongsheng, M.; Longley, J.B.; Metcalfe, D.D. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp. Hematol. 2003, 31 (8), 686-692.

34. Ma, Y.; Zeng, S.; Metcalfe, D.D.; Akin, C.; Dimitrijevic, S.; Butterfield, J.H.; McMahon, G.; Longley, B.J. The c-kit mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002, 99 (5), 17411744.

35. Liao, A.T.; Chien, M.B.; Shenoy, N.; Mendel, D.B.; McMahon, G.; Cherrington, J.M.; London, C.A. Inhibition of constitutively active forms of mutant kit by multi-targeted indolinone tyrosine kinase inhibitors. Blood 2002, 100 (2), 585-593.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment